Mirum rises on 2024 revenue forecast raise

Mirum Pharmaceuticals

12/11/2024 15:13

** Shares of Mirum Pharmaceuticals  MIRM.O  rise 5.7% to
$43.97
    ** Co raises 2024 rev. forecast to the range of $330 mln to
$335 mln from its prior range of $310 mln to $320 mln
    ** Posts Q3 rev. of $90.3 mln, above analysts' est. of $82.0
mln - LSEG
    ** Reports Q3 loss per share of 30 cents, smaller than
analysts' est. of 45 cents - LSEG
    ** Co's Livmarli, a liver disease drug, posts Q3 rev. of
$59.1 mln, above analysts' est of $50 mln - LSEG
    ** All 11 brokerages covering MIRM rate the stock "buy" or
higher; median PT is $65.50 - LSEG
    ** Stock has risen ~49% YTD, including session gains

 (Reporting by Kamal Choudhury in Bengaluru)
 ((Kamal.Choudhury@thomsonreuters.com))